Decreased Detection of Respiratory Syncytial Virus (RSV) in Children Coinfected with COVID-19

Strategic Insights -

Research conducted in Maharashtra, India, has revealed that the detection of Respiratory Syncytial Virus (RSV) has decreased in children coinfected with COVID-19. The study, published in the Indian Journal of Public Health, found that RSV-A was detected in 34% of cases, with the highest prevalence in school-going children aged 6-12 years. This highlights the importance of preventive measures and efficient antiviral medication to lower the illness load in young infants.

Key Takeaways:

  • The global impact of SARS-CoV-2 has raised concerns regarding the potential risk of respiratory viruses in children, with RSV and SARS-CoV-2 exhibiting similar clinical manifestations.
  • The detection of RSV has decreased in children coinfected with COVID-19, with RSV-A detected in 34% of cases.
  • The highest prevalence of RSV-A was found in school-going children aged 6-12 years, highlighting the significance of RSV-A as a prevalent viral pathogen among young children.
  • The study emphasizes the importance of preventive measures and/or efficient antiviral medication to lower the illness load in young infants.
  • The research was conducted at Dr. D. Y. Patil Medical College, Hospital and Research Centre in Pune, Maharashtra, India.
  • The study's findings highlight the need for continued surveillance of respiratory viruses in children and the development of effective treatments for RSV-A.

Statistics:

  • 106 cases were tested for RSV-A using polymerase chain reaction (PCR) from October 1, 2021, to March 31, 2022.
  • RSV-A was detected in 34% of cases, with the highest prevalence (25.5%) in school-going children aged 6-12 years.
  • Among the cases tested, 25.5% had a history of visit to a healthcare facility within 7 days prior to onset of symptoms.
  • The study's results reinforce the significance of RSV-A as a prevalent viral pathogen among young children.

Sources:

  • NewsRx. Research Conducted at Hospital and Research Centre Has Updated Our Knowledge about COVID-19 (Respiratory Syncytial Virus-A in Severe Acute Respiratory Syndrome Coronavirus-2-Negative Pediatric Patients: Insights from Tertiary Healthcare Center ...). Medical Letter on the CDC & FDA. October 26, 2025; p 162.
  • Respiratory Syncytial Virus-A in Severe Acute Respiratory Syndrome Coronavirus-2-Negative Pediatric Patients: Insights from Tertiary Healthcare Center in Pune. Indian Journal of Public Health, 2025;69(3):335-337.